title: Thermal antinociception after dexmedetomidine administration in cats: a dose-finding study.
abstract: The optimum dose of dexmedetomidine for antinociception to a thermal stimulus was determined in a crossover study of 12 cats. In five treatment groups (n = 10 per group), dexmedetomidine was administered intramuscularly (i.m.) at 2, 5, 10, 20 and 40 microg/kg; positive and negative controls were administered buprenorphine (20 microg/kg, i.m.) and 0.9% saline (0.006 mL/kg, i.m.) respectively. Baseline thermal thresholds and visual analogue scale (VAS) sedation scores were obtained prior to drug treatment and then at regular intervals until 24 h after administration. The summary measures of overall mean thresholds and overall mean VAS scores were investigated using a univariate general linear model for multiple factors with post hoc Tukey's tests (P < 0.05). Only dexmedetomidine at 40 microg/kg displayed an analgesic effect (less than that of buprenorphine). The VAS for sedation did not significantly affect the thresholds obtained and treatment was the only significant factor to influence VAS. Dexmedetomidine resulted in higher VAS for sedation than saline and buprenorphine. Dexmedetomidine at 40 microg/kg significantly increased nociceptive thresholds compared with saline control, but less than buprenorphine. Dexmedetomidine produced dose-dependent sedation, but only the highest dose produced analgesia, suggesting that induction of analgesia requires the highest dose (or an additional analgesic) in the clinical setting.
authors.affiliation: Division of Companion Animals, School of Clinical Veterinary Science, University of Bristol, Bristol, UK. louisa.slingsby@bristol.ac.uk
authors.forename: L S
authors.initials: LS
authors.lastname: Slingsby
authors.forename: P M
authors.initials: PM
authors.lastname: Taylor
mesh_terms: D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage*; D000818:Animals; D002415:Cats; D018592:Cross-Over Studies; D020927:Dexmedetomidine / Q000008:administration & dosage*; D005260:Female; D006358:Hot Temperature; D007273:Injections, Intramuscular / Q000662:veterinary; D008297:Male; D010146:Pain / Q000517:prevention & control / Q000662:veterinary*; D010147:Pain Measurement / Q000187:drug effects / Q000662:veterinary
chemical_list: D018712:Analgesics, Non-Narcotic; D020927:Dexmedetomidine